ORIA
Orion Biotech Opportunities Corp. Class A Ordinary Share
ORIA
ORIA
Delisted
ORIA was delisted on the 28th of April, 2023.
52 hedge funds and large institutions have $142M invested in Orion Biotech Opportunities Corp. Class A Ordinary Share in 2022 Q3 according to their latest regulatory filings, with 8 funds opening new positions, 8 increasing their positions, 9 reducing their positions, and 3 closing their positions.
New
Increased
Maintained
Reduced
Closed
more first-time investments, than exits
New positions opened: | Existing positions closed:
more capital invested
Capital invested by funds: $ → $
more funds holding
Funds holding: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
Holders
52
Holding in Top 10
–
Calls
–
Puts
–
Top Buyers
| 1 | +$4.85M | |
| 2 | +$3.72M | |
| 3 | +$3.7M | |
| 4 |
AC
Aristeia Capital
Greenwich,
Connecticut
|
+$2.46M |
| 5 |
Millennium Management
New York
|
+$1.19M |
Top Sellers
| 1 | -$4.87M | |
| 2 | -$1.26M | |
| 3 | -$1.08M | |
| 4 |
HighTower Advisors
Chicago,
Illinois
|
-$708K |
| 5 |
BCM
Basso Capital Management
Stamford,
Connecticut
|
-$488K |